SI1761520T1 - Inhibitorji kinaze - Google Patents
Inhibitorji kinazeInfo
- Publication number
- SI1761520T1 SI1761520T1 SI200530351T SI200530351T SI1761520T1 SI 1761520 T1 SI1761520 T1 SI 1761520T1 SI 200530351 T SI200530351 T SI 200530351T SI 200530351 T SI200530351 T SI 200530351T SI 1761520 T1 SI1761520 T1 SI 1761520T1
- Authority
- SI
- Slovenia
- Prior art keywords
- kinase inhibitors
- formula
- present
- inhibitors
- provides kinase
- Prior art date
Links
- 229940043355 kinase inhibitor Drugs 0.000 title abstract 2
- 239000003757 phosphotransferase inhibitor Substances 0.000 title abstract 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04380131A EP1609789A1 (en) | 2004-06-23 | 2004-06-23 | Ureido-pyrazole derivatives and their use as kinase inhibitors |
| US59253904P | 2004-07-30 | 2004-07-30 | |
| EP04380174 | 2004-08-23 | ||
| US62249204P | 2004-10-27 | 2004-10-27 | |
| EP05766569A EP1761520B1 (en) | 2004-06-23 | 2005-06-15 | Kinase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI1761520T1 true SI1761520T1 (sl) | 2008-10-31 |
Family
ID=43875180
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI200530351T SI1761520T1 (sl) | 2004-06-23 | 2005-06-15 | Inhibitorji kinaze |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7767674B2 (sl) |
| EP (1) | EP1761520B1 (sl) |
| AT (1) | ATE400567T1 (sl) |
| DK (1) | DK1761520T3 (sl) |
| ES (1) | ES2308523T3 (sl) |
| PL (1) | PL1761520T3 (sl) |
| PT (1) | PT1761520E (sl) |
| SI (1) | SI1761520T1 (sl) |
| WO (1) | WO2006009741A1 (sl) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2520763A1 (en) | 2003-04-03 | 2004-10-21 | The Regents Of The University Of California | Improved inhibitors for the soluble epoxide hydrolase |
| CA2559665A1 (en) | 2004-03-16 | 2005-09-29 | The Regents Of The University Of California | Reducing nephropathy with inhibitors of soluble epoxide hydrolase and epoxyeicosanoids |
| US7662910B2 (en) | 2004-10-20 | 2010-02-16 | The Regents Of The University Of California | Inhibitors for the soluble epoxide hydrolase |
| PE20070640A1 (es) * | 2005-10-28 | 2007-08-10 | Lilly Co Eli | Compuestos derivados de pirazol-isoquinolina urea como inhibidores de la cinasa p38 |
| PE20070795A1 (es) * | 2005-10-28 | 2007-08-24 | Lilly Co Eli | Compuestos pirazol-urea-heterociclicos como inhibidores de cinasa |
| AR059826A1 (es) * | 2006-03-13 | 2008-04-30 | Univ California | Inhibidores de urea conformacionalmente restringidos de epoxido hidrolasa soluble |
| EP1992344A1 (en) | 2007-05-18 | 2008-11-19 | Institut Curie | P38 alpha as a therapeutic target in pathologies linked to FGFR3 mutation |
| WO2009002916A2 (en) * | 2007-06-26 | 2008-12-31 | Smithkline Beecham Corporation | Processes for preparing benzimidazole thiophenes |
| US8314091B2 (en) | 2007-08-20 | 2012-11-20 | Msd Oss B.V. | N-benzyl,N'-arylcarbonylpiperazine derivatives |
| RU2474575C2 (ru) | 2008-03-26 | 2013-02-10 | Дайити Санкио Компани, Лимитед | Новое производное тетрагидроизохинолина, фармацевтическая композиция на его основе, применение его и способ лечения и/или предотвращения заболевания |
| TW201022230A (en) * | 2008-08-28 | 2010-06-16 | Organon Nv | 1-(4-ureidobenzoyl)piperazine derivatives |
| GB0818033D0 (en) | 2008-10-02 | 2008-11-05 | Respivert Ltd | Novel compound |
| PE20110598A1 (es) | 2008-10-02 | 2011-08-31 | Respivert Ltd | Inhibidores de las enzimas de proteina cinasa activadas por mitogeno p38 |
| MX2011006220A (es) | 2008-12-11 | 2011-06-28 | Respivert Ltd | Inhibidores de la proteina cinasa activada por el mitogeno p38. |
| AU2010215261A1 (en) | 2009-02-17 | 2011-09-08 | Chiesi Farmaceutici S.P.A. | Triazolopyridine derivatives as p38 MAP kinase inhibitors |
| GB0905955D0 (en) | 2009-04-06 | 2009-05-20 | Respivert Ltd | Novel compounds |
| EP2488511A1 (en) * | 2009-10-02 | 2012-08-22 | Vertex Pharmaceuticals Incorporated | Pyrazole inhibitors of phosphatidylinositol 3-kinase |
| US9452980B2 (en) | 2009-12-22 | 2016-09-27 | Hoffmann-La Roche Inc. | Substituted benzamides |
| EP2528604B1 (en) | 2010-01-29 | 2017-11-22 | The Regents of the University of California | Acyl piperidine inhibitors of soluble epoxide hydrolase |
| GB201009731D0 (en) | 2010-06-10 | 2010-07-21 | Pulmagen Therapeutics Inflamma | Kinase inhibitors |
| WO2013083604A1 (en) | 2011-12-09 | 2013-06-13 | Chiesi Farmaceutici S.P.A. | Kinase inhibitors |
| SG10201604656YA (en) | 2011-12-09 | 2016-07-28 | Chiesi Farma Spa | Kinase inhibitors |
| US9150570B2 (en) * | 2012-05-31 | 2015-10-06 | Plexxikon Inc. | Synthesis of heterocyclic compounds |
| CN105377847A (zh) | 2013-06-06 | 2016-03-02 | 奇斯药制品公司 | 激酶抑制剂 |
| WO2017108736A1 (en) | 2015-12-23 | 2017-06-29 | Chiesi Farmaceutici S.P.A. | N-[3-(3-{4-[[1,2,4]triazolo[4,3-a]pyridin-6-yloxy]-1,2,3,4-tetrahydro-naphthalen-1-yl} -ureido)-phenyl]-methanesulfonamide derivatives and their use as p38 mapk inhibitors |
| AR107165A1 (es) | 2015-12-23 | 2018-03-28 | Chiesi Farm Spa | Inhibidores de quinasa |
| PE20181446A1 (es) | 2016-03-17 | 2018-09-12 | Hoffmann La Roche | Derivados de 5-etil-4-metil-pirazol-3-carboxamida con actividad como de taar |
| CN107619388A (zh) | 2016-07-13 | 2018-01-23 | 南京天印健华医药科技有限公司 | 作为fgfr抑制剂的杂环化合物 |
| CN107840842A (zh) | 2016-09-19 | 2018-03-27 | 北京天诚医药科技有限公司 | 炔代杂环化合物、其制备方法及其在医药学上的应用 |
| US10342786B2 (en) | 2017-10-05 | 2019-07-09 | Fulcrum Therapeutics, Inc. | P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD |
| PT3691620T (pt) | 2017-10-05 | 2022-10-06 | Fulcrum Therapeutics Inc | Os inibidores da quinase p38 reduzem a expressão de dux4 e genes a jusante para o tratamento de fshd |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA73492C2 (en) * | 1999-01-19 | 2005-08-15 | Aromatic heterocyclic compounds as antiinflammatory agents | |
| ID30176A (id) * | 1999-03-12 | 2001-11-08 | Boehringer Ingelheim Pharma | Senyawa-senyawa yang bermanfaat sebagai zat anti-inflamasi |
| WO2003072569A1 (en) * | 2002-02-25 | 2003-09-04 | Boehringer Ingelheim Pharmaceuticals, Inc. | 1,4-disubstituted benzofused cycloalkyl urea compounds useful in treating cytokine mediated diseases |
| GB0320244D0 (en) | 2003-05-06 | 2003-10-01 | Aventis Pharma Inc | Pyrazoles as inhibitors of tumour necrosis factor |
| US20070010529A1 (en) * | 2003-05-19 | 2007-01-11 | Kanji Takahashi | Nitrogenous heterocyclic compounds and medical use thereof |
-
2005
- 2005-06-15 ES ES05766569T patent/ES2308523T3/es not_active Expired - Lifetime
- 2005-06-15 PT PT05766569T patent/PT1761520E/pt unknown
- 2005-06-15 SI SI200530351T patent/SI1761520T1/sl unknown
- 2005-06-15 WO PCT/US2005/021148 patent/WO2006009741A1/en not_active Ceased
- 2005-06-15 DK DK05766569T patent/DK1761520T3/da active
- 2005-06-15 EP EP05766569A patent/EP1761520B1/en not_active Expired - Lifetime
- 2005-06-15 AT AT05766569T patent/ATE400567T1/de not_active IP Right Cessation
- 2005-06-15 PL PL05766569T patent/PL1761520T3/pl unknown
- 2005-06-15 US US11/569,809 patent/US7767674B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP1761520A1 (en) | 2007-03-14 |
| DK1761520T3 (da) | 2008-10-27 |
| US20080306068A1 (en) | 2008-12-11 |
| ATE400567T1 (de) | 2008-07-15 |
| EP1761520B1 (en) | 2008-07-09 |
| WO2006009741A1 (en) | 2006-01-26 |
| ES2308523T3 (es) | 2008-12-01 |
| US7767674B2 (en) | 2010-08-03 |
| PT1761520E (pt) | 2008-09-15 |
| PL1761520T3 (pl) | 2008-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL1761520T3 (pl) | Inhibitory kinazy | |
| TW200640924A (en) | VEGF-R2 inhibitors and methods | |
| IL163781A0 (en) | Purine derivatives as kinase inhibitors | |
| IL163777A0 (en) | Kinase inhibitors | |
| MX2009007077A (es) | Analogos de ciclopamina. | |
| CY1109911T1 (el) | Πυρρολοβενζοδιαζεπινες | |
| PT1940839E (pt) | Inibidores de piridopirimidinona pi3k alfa | |
| TNSN08191A1 (en) | Kinase inhibitors | |
| ZA200701137B (en) | Triazolophthalazines | |
| CY1109234T1 (el) | Αναστολεις κινασης | |
| EA200971051A1 (ru) | Ингибиторы p70 s6 киназы | |
| TN2011000293A1 (en) | Protein kinase inhibitors | |
| MY169515A (en) | Quinazolinedione derivatives as parp inhibitors | |
| SG154433A1 (en) | Phthalazine derivatives as parp inhibitors | |
| TW200740815A (en) | P38 MAP kinase inhibitors and methods for using the same | |
| UA85593C2 (uk) | Похідні хіназолінону як інгібітори parp | |
| MX2007008137A (es) | Triazoloftalazinas como inhibidores de pde2. | |
| MX2010010406A (es) | Tetrahidrofenantridinonas y tetrahidrociclopentaquinolinonas como inhibidores de la polimerizacion de poli(adp-ribosa)polimerasa-1 y tubulina. | |
| JO2822B1 (en) | Inhibitors of the enzyme kinase P70 S6 and AKT | |
| TW200624426A (en) | BACE inhibitors | |
| EA201200891A1 (ru) | Производные 3,4,4a,10d-тетрагидро-1h-тиопирано[4,3-c]изохинолина | |
| MX2008001538A (es) | Aril piridinas y metodos para su uso. | |
| EA200801145A1 (ru) | Спироциклические производные хиназолина в качестве ингибиторов pde7 | |
| ATE548364T1 (de) | Aminopyrazolkinasehemmer | |
| DOP2005000117A (es) | Inhibidores de quinasa |